mine whether these residues play a role in charge transfer. In rabbit SGLT1 we have mutated Asp-176 to asparagine and to alanine and measured charge transfer. Dramatic changes occurred with the Aspl76Ala mutant, i.e. V,,,s decreased from + 1 to -46 mV and the z decreased with depolarization instead of increasing. This result alone would suggest that Asp-176 is a charged residue directly involved in sensing the membrane field, but the Asp 176Asn mutation only produced modest changes in charge-transfer kinetics. W e conclude that polar residues, and not necessarily charged residues, constitute the charge sensor in SGLT1.
mine whether these residues play a role in charge transfer. In rabbit SGLT1 we have mutated Asp-176 to asparagine and to alanine and measured charge transfer. Dramatic changes occurred with the Aspl76Ala mutant, i.e. V,,,s decreased from + 1 to -46 mV and the z decreased with depolarization instead of increasing. This result alone would suggest that Asp-176 is a charged residue directly involved in sensing the membrane field, but the Asp 176Asn mutation only produced modest changes in charge-transfer kinetics. W e conclude that polar residues, and not necessarily charged residues, constitute the charge sensor in SGLT1.
W e are presently extending our studies to other cloned transporters. In general, the results so far indicate that the steady-state and pre-steadystate kinetics of Na+-Ins, H+-glucose and Na+ -CI--taurine cotransporters have much in common with SGLT1.
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Introduction
The i)-galactose-H+ symporter (GalP) from Escherichia coli shares sequence similarity with the GLUT family of mammalian glucose transporters [ 1-61. As a consequence the GalP and GLUT proteins are predicted to have a similar membrane topology, comprising 12 membrane-spanning ahelices, with helices 6 and 7 connected by a cytoplasmic domain composed of 60-70 amino acids . Moreover, GalP has many properties in common with mammalian glucose transporters. The sugar specificity of GalP is very similar to that of the human erythrocyte (G1,UTl) and the rat adipocyte (GLUT4) glucose transporters and GalP-mediated sugar transport can be inhibited by the antibiotics cytochalasin I3 and forskolin [3, 11, , which are potent inhibitors of glucose transporters [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . The GLUT1 and GalP proteins can be photolabelled by these antibiotics, or Abbreviations used: ANS, X-anilino-l-naphthalenesulphonic acid; CH, cytochalasin H; F, forskolin. $To whom correspondence should be addressed. derivatives of them, in a 1)-glucose-inhibitable manner [8, 11, 13, 14, . The tryptic digestion of the GalP protein, which has been photolabelled with cytochalasin H, produces a labelled fragment (Mr 17000-19000) of almost identical Mr to that produced by digestion of GLUT1 [ 1 11.
The efficiency of photolabelling GLUT1 with antibiotics is maximal at 280 nm, suggesting that a tryptophan residue in one of these helices may be activated before the covalent attachment of the antibiotic. Moreover, the binding of antibiotics induces a conformational change in GLUT1, where the environment around one or more of the tryptophans must be perturbed. The binding site(s) for cytochalasin B and forskolin have been localized between a-helices 10 and 11 by identifying the photolabelled proteolytic fragments from GLUT 1 [28-331. Two tryptophan residues within this region, Trp-388 and Trp-412, lie towards the cytoplasmic end of helices 10 and 11 respectively [7] . Furthermore, cytochalasin B is thought to bind to the inward-or cytoplasmic-facing site [ 19,341 so that these tryptophan residues seem likely candi-dates for forming a dynamic segment of the transporter. The role of these residues has been investigated in several studies, in which mutant proteins, produced by site-directed mutagenesis, were tested for their ability to bind antibiotics and transport sugars [ 35-38 1. I Iowever, the eukaryotic expression systems used did not provide sufficient amounts of the mutant proteins to allow them to be characterized in detail. The only firm conclusion reached by these studies is that neither Trp-388 nor Trp-41 2 is essential for labelling with either cytochalasin I3 or forskolin.
The alignment of the amino acid sequence for (hlP with that of (;I,CWl indicates that these tryptophan residues are conserved in (;alP, and indeed within the family of (;I,U7' proteins 161. It seems highly likely that these residues, Trp-371 and
Trp-305 respectively in the GalP sequence [8] , will play similar roles in the function of the GalP and GIAJT proteins. 
Binding of antibiotics
The binding of cytochalasin H and forskolin induces a quench in the protein tluorescence of both GLUT1 and GalP [13] [14] [15] 20, 22, 39, 40] . This observation has allowed the kinetics of the binding of cytochalasin H to GLUT 1 and GalP to be monitored by fluorescence spectroscopy [ 151. The overall affinities of these sugar transporters for cytochalasin H has been determined by titration of the protein fluorescence, while the association and dissociation rate constants for the binding of cytochalasin €3 have been determined by stopped-flow fluorescence spectroscopy (Table 1 ). The latter kinetic parameters were obtained from the gradient and intercept respectively of a linear fit of the rate of binding as a function of the cytochalasin H concentration. In the case of GalP, the dissociation constant (K?) calculated from the association and dissociation rate constants is lower than that obtained by titration, but the reverse situation holds for GILJI'l. The apparent discrepancies between these values can be explained by the following model:
in which TI and T, are respectively the outwardand inward-facing forms of the unloaded transporters, and T,(CH) and T,(CH) are two different conformations of the transporter-cytochalasin H (CB)
complex. For such a model the apparent dissociation constant of the transporter-CH complex is given by:
with K,, K, and K , defined as K,=k-,/k,, K , = k-,/k, and K , = k -/ k 3 .
In the case of GLUT1, k, and k -I (and hence K , ) are known [41, 42] and so K , can be calculated as 0.074 by substituting K , (k, = 600 s-I, k -, = 148 s-I and K , = 0.247 at 20°C [41] ) and the measured Table 1 Kinetic parameters for the binding of cytochalasin B and forskolin to GalP and GLUT1 at 20°C k , and k -2 are the association and dissociation rate constants respectively for the binding of the specified antibiotic They were determined from the gradient and slope respectively of a linear fit of the concentration dependence of the rate of binding of the antibiotics, which was determined by mixing the antibiotic with the sugar transporters in a stopped-flow device and monitoring the rate of quench in protein fluorescence The affinity of the transporters were calculated from the measured association and dissociation rate constants ( K 2 = k _ , l k 2 ) The overall affinity of the transporters for the specified antibiotics were determined by the steady-state titration of the protein fluorescence with the antibiotic in a fluorimeter, monitoring the quench in protein fluorescence as the antibiotic concentration was increased is evident that at 20°C the outward-facing conformation predominates for GalP.
The rate of binding of forskolin was also linearly dependent upon the forskolin concentration, yielding the association and dissociation rate constants given in Table 1 . The value calculated for the dissociation constant (K,) was similar to that obtained by titration, indicating that K , must hzve a similar value to K , (Table 1 and [ 13,141).
In contrast, a Trp395Phe mutant of GalP was characterized by an apparently hyperbolic increase in the rate of binding. These data provide clear evidence that the transporter-forskolin (F) complex undergoes a further conformational change, the T,(F) to T,(F) transition. Presumably, for the wildtype protein this transition occurs at a rate that is too fast to be measured by stopped-flow fluorescence spectroscopy. The data were fitted to a hyperbolic function, yielding minimal and maximal values for k , and k -, of 3.6s-' and 28.4s-' respectively and an apparent K , of 3.7pM. These values will correspond to those for k3, k -, and K, respectively in scheme I. Using these values and the measured K , (0.58pM), K , can be calculated as 0.41 from eqn. 1.
This mutation has caused a large shift in the equilibrium between T, and T,, so that -29% of the transporters are in the TI (or outward-facing) conformation in the absence of ligands, while stabilizing the T,(F) complex ( K , = 7.7). After equilibration with forskolin, the GalP-F complex is present as 11.3% T,(F) and 88.7% T,(F). Furthermore, the affinity of the T, conformation for forskolin was On the other hand, the binding of cytochalasin €3 to the Trp395Phe mutant GalP was characterized by a linear increase in the rate of binding; yielding association and dissociation rate constants of 0.6pM-'*s-' and 10.5 s -' respectively. The T, conformation has a lower affinity ( K , 17.5 pM) than the overall affinity ( K , 6.7 pM), again indicating that there must be a further isomerization of the T,(antibiotic) complex.
Hence, these studies suggest that the binding of antibiotics to both GLUT1 and GalP involve at least three steps: a transition from an outward-to an inward-facing conformation, binding of the antibiotics and induction of a further conformational change in the transporter-antibiotic complex. The exact nature of the latter transition is not known, but one possibility is that it is a partial reorientation of the transporters.
The Trp371Phe mutation in GalP did not cause a substantial perturbation in the kinetics of either the binding of cytochalasin H or forskolin and the overall affinity of the mutant for these antibiotics was similar to the wild-type.
Binding of sugars
The binding of sugars (and antibiotics) to GalP can be monitored from the changes in the fluorescence of 8-anilino-1 -napthalenesulphonic acid (ANS) equilibrated with inside-out vesicles [ 121. Transported sugars, such as r)-glucose and i)-galactose, cause an enhancement in the ANS fluorescence, of up to 13%, and the overall affinity of GalP for these sugars can be obtained by fluorescence titration. Non-transported sugars that have little, if any, affinity for GalP, such as [,-galactose and [,-glucose, have no effect upon the ANS fluorescence. Cytochalasin R and forskolin, which are potent inhibitors of the transporter, produce little change in the fluorescence, but are capable of reversing the i)-galactose/l)-glucose enhancement in fluorescence. Sugars that bind to GalP but are not transported, such as methyl p-i)-glucose, produce only a slight quench in the ANS fluorescence, but again reverse the enhancement in fluorescence induced by transported sugars. A simple interpretation of these findings is that the increase in ANS fluorescence is attributable to the sugar-induced reorientation of the transporter from an inward-to an outwardfacing conformation. Non-transported sugars and antibiotics, which are thought to bind at the inner membrane face of the transporter, are able to where T(, and T, are the inward-and outwardfacing conformations of the transporter. TZ is an additional outward-facing conformation that must differ in structure to T,,, but in an unknown manner.
A model for sugar and antibiotic binding
The kinetic models derived from the binding of antibiotics and for the binding and translocation of sugars can be accommodated into a single kinetic model, which represents the minimal translocation cycle under non-energizing conditions: This kinetic model will be used as the bench mark against which the kinetics of mutants generated in CalP can be compared and hence will be of immense importance in eluminating structure-function relationships in this important class of transporters 
